Jonathan Roach
Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Neoplasms | 12 | 2026 | 780 | 1.930 |
Why?
| | Biliary Atresia | 6 | 2022 | 157 | 1.770 |
Why?
| | Hepatoblastoma | 9 | 2026 | 52 | 1.700 |
Why?
| | Medical Errors | 2 | 2025 | 118 | 1.350 |
Why?
| | Surgical Oncology | 8 | 2026 | 30 | 1.240 |
Why?
| | Specialties, Surgical | 2 | 2022 | 81 | 1.210 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2026 | 192 | 1.060 |
Why?
| | Pancreatic Neoplasms | 2 | 2026 | 918 | 1.050 |
Why?
| | Adrenal Cortex Neoplasms | 2 | 2025 | 65 | 1.010 |
Why?
| | Adrenocortical Carcinoma | 2 | 2025 | 67 | 1.010 |
Why?
| | Hepatectomy | 2 | 2026 | 273 | 0.990 |
Why?
| | Pancreatectomy | 2 | 2026 | 285 | 0.970 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2026 | 1137 | 0.960 |
Why?
| | Kidney Neoplasms | 7 | 2026 | 412 | 0.960 |
Why?
| | Liver Transplantation | 6 | 2024 | 822 | 0.920 |
Why?
| | Laparoscopy | 4 | 2026 | 475 | 0.910 |
Why?
| | Carcinoma, Papillary | 1 | 2025 | 78 | 0.880 |
Why?
| | Appointments and Schedules | 1 | 2025 | 97 | 0.850 |
Why?
| | Child | 42 | 2026 | 22537 | 0.790 |
Why?
| | Catheterization, Central Venous | 1 | 2025 | 122 | 0.780 |
Why?
| | Portoenterostomy, Hepatic | 3 | 2022 | 43 | 0.680 |
Why?
| | Child, Preschool | 21 | 2026 | 11774 | 0.630 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2024 | 370 | 0.630 |
Why?
| | Choledocholithiasis | 3 | 2025 | 20 | 0.620 |
Why?
| | Gallstones | 3 | 2025 | 34 | 0.620 |
Why?
| | Survival Rate | 10 | 2026 | 2088 | 0.610 |
Why?
| | Bile Acids and Salts | 1 | 2020 | 164 | 0.590 |
Why?
| | Surgeons | 2 | 2025 | 338 | 0.590 |
Why?
| | Pediatrics | 3 | 2025 | 1112 | 0.570 |
Why?
| | Infant | 20 | 2026 | 10022 | 0.540 |
Why?
| | Cholestasis | 1 | 2020 | 219 | 0.530 |
Why?
| | Neoplasms | 4 | 2025 | 2870 | 0.520 |
Why?
| | Quality Improvement | 2 | 2025 | 1285 | 0.500 |
Why?
| | Wilms Tumor | 3 | 2023 | 85 | 0.480 |
Why?
| | Appendectomy | 3 | 2023 | 89 | 0.470 |
Why?
| | Retrospective Studies | 27 | 2026 | 17009 | 0.460 |
Why?
| | Patient Safety | 1 | 2019 | 347 | 0.450 |
Why?
| | Adrenalectomy | 2 | 2025 | 71 | 0.440 |
Why?
| | Nephrectomy | 4 | 2026 | 158 | 0.440 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 355 | 0.440 |
Why?
| | Pancreaticoduodenectomy | 2 | 2026 | 135 | 0.420 |
Why?
| | Accidents | 1 | 2014 | 45 | 0.420 |
Why?
| | Humans | 55 | 2026 | 144261 | 0.420 |
Why?
| | Adolescent | 23 | 2026 | 22281 | 0.410 |
Why?
| | MicroRNAs | 1 | 2020 | 700 | 0.410 |
Why?
| | Appendicitis | 2 | 2023 | 148 | 0.400 |
Why?
| | Digestive System Diseases | 1 | 2013 | 27 | 0.400 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 73 | 0.380 |
Why?
| | Cholecystectomy, Laparoscopic | 2 | 2023 | 54 | 0.380 |
Why?
| | Abdomen | 1 | 2013 | 141 | 0.370 |
Why?
| | Sarcoma | 3 | 2024 | 205 | 0.350 |
Why?
| | Child Abuse | 2 | 2014 | 550 | 0.350 |
Why?
| | Postoperative Complications | 4 | 2026 | 2916 | 0.340 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 597 | 0.340 |
Why?
| | Internship and Residency | 1 | 2022 | 1255 | 0.330 |
Why?
| | Kidney Transplantation | 1 | 2017 | 704 | 0.330 |
Why?
| | Organ Transplantation | 1 | 2013 | 247 | 0.310 |
Why?
| | Tissue Donors | 1 | 2013 | 424 | 0.310 |
Why?
| | Bile Ducts | 2 | 2020 | 67 | 0.300 |
Why?
| | Brain Injuries | 1 | 2014 | 506 | 0.290 |
Why?
| | Blood Substitutes | 1 | 2009 | 28 | 0.290 |
Why?
| | Inflammation | 1 | 2020 | 2877 | 0.290 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 74 | 0.280 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2025 | 219 | 0.280 |
Why?
| | Abdominal Abscess | 1 | 2007 | 25 | 0.270 |
Why?
| | Cellulitis | 1 | 2007 | 53 | 0.260 |
Why?
| | Drainage | 1 | 2007 | 185 | 0.250 |
Why?
| | Cytokines | 2 | 2018 | 2061 | 0.250 |
Why?
| | Hemoglobins | 1 | 2009 | 383 | 0.240 |
Why?
| | Lung Neoplasms | 3 | 2026 | 2637 | 0.240 |
Why?
| | Neoplasm Staging | 3 | 2025 | 1461 | 0.240 |
Why?
| | Female | 24 | 2026 | 77976 | 0.240 |
Why?
| | Conversion to Open Surgery | 1 | 2026 | 22 | 0.240 |
Why?
| | Indocyanine Green | 1 | 2026 | 42 | 0.240 |
Why?
| | Metastasectomy | 1 | 2026 | 19 | 0.230 |
Why?
| | Esophageal Atresia | 1 | 2026 | 30 | 0.230 |
Why?
| | Sentinel Lymph Node | 1 | 2026 | 49 | 0.230 |
Why?
| | Tracheoesophageal Fistula | 1 | 2026 | 38 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2730 | 0.230 |
Why?
| | Near Miss, Healthcare | 1 | 2025 | 12 | 0.230 |
Why?
| | Operative Time | 1 | 2026 | 175 | 0.230 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2026 | 118 | 0.230 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 863 | 0.230 |
Why?
| | Carcinoma, Medullary | 1 | 2025 | 16 | 0.220 |
Why?
| | Intraoperative Care | 1 | 2025 | 62 | 0.220 |
Why?
| | Length of Stay | 3 | 2026 | 1335 | 0.220 |
Why?
| | Male | 23 | 2026 | 72035 | 0.220 |
Why?
| | Rhabdoid Tumor | 1 | 2026 | 103 | 0.220 |
Why?
| | Soft Tissue Neoplasms | 1 | 2026 | 127 | 0.210 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 5 | 0.210 |
Why?
| | Databases, Factual | 3 | 2026 | 1484 | 0.210 |
Why?
| | Mesenteric Veins | 1 | 2024 | 23 | 0.210 |
Why?
| | Pancreatitis | 1 | 2025 | 142 | 0.210 |
Why?
| | Clinical Protocols | 1 | 2026 | 282 | 0.210 |
Why?
| | Pancreas | 1 | 2026 | 341 | 0.200 |
Why?
| | Appendiceal Neoplasms | 1 | 2023 | 28 | 0.200 |
Why?
| | Robotic Surgical Procedures | 1 | 2026 | 182 | 0.200 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2023 | 16 | 0.190 |
Why?
| | Sarcoma, Ewing | 1 | 2024 | 102 | 0.190 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 75 | 0.190 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2023 | 32 | 0.190 |
Why?
| | Combined Modality Therapy | 4 | 2026 | 1264 | 0.190 |
Why?
| | United States | 5 | 2025 | 15876 | 0.190 |
Why?
| | Follow-Up Studies | 7 | 2026 | 5389 | 0.180 |
Why?
| | Documentation | 1 | 2024 | 197 | 0.180 |
Why?
| | Infant, Newborn | 6 | 2026 | 6424 | 0.180 |
Why?
| | Treatment Outcome | 6 | 2026 | 11643 | 0.180 |
Why?
| | Prognosis | 6 | 2026 | 4278 | 0.180 |
Why?
| | Blood Transfusion | 1 | 2025 | 405 | 0.180 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2022 | 23 | 0.180 |
Why?
| | Registries | 2 | 2025 | 2382 | 0.180 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2022 | 21 | 0.180 |
Why?
| | Academic Medical Centers | 1 | 2025 | 545 | 0.180 |
Why?
| | Neuroendocrine Tumors | 1 | 2023 | 112 | 0.180 |
Why?
| | Bone Neoplasms | 1 | 2024 | 253 | 0.170 |
Why?
| | CD79 Antigens | 1 | 2020 | 16 | 0.160 |
Why?
| | Thoracic Wall | 1 | 2020 | 21 | 0.160 |
Why?
| | Thoracic Neoplasms | 1 | 2020 | 39 | 0.160 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 27 | 0.160 |
Why?
| | Cell Line | 2 | 2020 | 2879 | 0.160 |
Why?
| | Age Factors | 2 | 2025 | 3313 | 0.160 |
Why?
| | Young Adult | 6 | 2026 | 13990 | 0.150 |
Why?
| | Hepatocytes | 1 | 2020 | 221 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2025 | 1409 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 109 | 0.150 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 209 | 0.140 |
Why?
| | Skin Neoplasms | 1 | 2026 | 847 | 0.140 |
Why?
| | Scoliosis | 1 | 2020 | 223 | 0.130 |
Why?
| | Membrane Glycoproteins | 1 | 2020 | 496 | 0.130 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 6021 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2024 | 725 | 0.130 |
Why?
| | Critical Pathways | 1 | 2018 | 106 | 0.130 |
Why?
| | Clinical Competence | 1 | 2025 | 1241 | 0.120 |
Why?
| | Job Satisfaction | 1 | 2019 | 240 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2020 | 736 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2024 | 1169 | 0.120 |
Why?
| | Postoperative Care | 1 | 2018 | 288 | 0.120 |
Why?
| | Perioperative Care | 1 | 2017 | 230 | 0.110 |
Why?
| | Liver | 2 | 2020 | 1884 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 32 | 0.110 |
Why?
| | Choledochal Cyst | 1 | 2013 | 17 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4556 | 0.100 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2013 | 62 | 0.100 |
Why?
| | Lymph Node Excision | 2 | 2025 | 173 | 0.100 |
Why?
| | Patient Selection | 1 | 2017 | 719 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1131 | 0.100 |
Why?
| | Mice, Knockout | 1 | 2020 | 3119 | 0.100 |
Why?
| | Bilirubin | 2 | 2023 | 97 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 876 | 0.090 |
Why?
| | Forecasting | 1 | 2014 | 388 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 176 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2603 | 0.080 |
Why?
| | Preoperative Care | 1 | 2013 | 379 | 0.080 |
Why?
| | Time Factors | 3 | 2018 | 7155 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1487 | 0.080 |
Why?
| | Mice | 3 | 2020 | 18329 | 0.080 |
Why?
| | Protoporphyrins | 1 | 2009 | 14 | 0.070 |
Why?
| | Enzyme Induction | 1 | 2009 | 88 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 121 | 0.070 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 85 | 0.070 |
Why?
| | Adult | 5 | 2025 | 40262 | 0.070 |
Why?
| | Gelsolin | 1 | 2007 | 10 | 0.070 |
Why?
| | Aged | 2 | 2025 | 25850 | 0.070 |
Why?
| | Intestinal Perforation | 1 | 2007 | 44 | 0.070 |
Why?
| | Lymph | 1 | 2007 | 31 | 0.070 |
Why?
| | Colorado | 2 | 2014 | 4562 | 0.070 |
Why?
| | Middle Aged | 2 | 2025 | 35762 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 2026 | 30 | 0.060 |
Why?
| | Animals | 4 | 2020 | 38030 | 0.060 |
Why?
| | Tuberous Sclerosis | 1 | 1986 | 56 | 0.060 |
Why?
| | Thoracoscopy | 1 | 2026 | 62 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 618 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 824 | 0.060 |
Why?
| | Cholecystectomy | 1 | 2025 | 59 | 0.060 |
Why?
| | Shock, Hemorrhagic | 1 | 2007 | 201 | 0.060 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2024 | 15 | 0.050 |
Why?
| | Lymphatic Metastasis | 1 | 2026 | 333 | 0.050 |
Why?
| | Pylorus | 1 | 2024 | 17 | 0.050 |
Why?
| | Image-Guided Biopsy | 1 | 2024 | 41 | 0.050 |
Why?
| | Disease-Free Survival | 1 | 2026 | 768 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2024 | 87 | 0.050 |
Why?
| | Enteral Nutrition | 1 | 2026 | 216 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2026 | 964 | 0.050 |
Why?
| | Remission Induction | 1 | 2024 | 306 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 329 | 0.050 |
Why?
| | Aspartate Aminotransferases | 1 | 2023 | 85 | 0.050 |
Why?
| | Recurrent Laryngeal Nerve | 1 | 2023 | 3 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 14 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2024 | 174 | 0.050 |
Why?
| | Lipase | 1 | 2023 | 74 | 0.050 |
Why?
| | Nephrons | 1 | 2022 | 23 | 0.050 |
Why?
| | Alanine Transaminase | 1 | 2023 | 151 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2023 | 64 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 88 | 0.050 |
Why?
| | Lymphoma | 1 | 2024 | 232 | 0.050 |
Why?
| | Thyroidectomy | 1 | 2023 | 90 | 0.050 |
Why?
| | Methylene Blue | 1 | 2022 | 24 | 0.050 |
Why?
| | Kidney Diseases | 1 | 1986 | 425 | 0.050 |
Why?
| | Patient Readmission | 1 | 2007 | 756 | 0.040 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2022 | 48 | 0.040 |
Why?
| | Prospective Studies | 2 | 2026 | 7970 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1075 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2024 | 462 | 0.040 |
Why?
| | Societies, Medical | 1 | 2025 | 886 | 0.040 |
Why?
| | Universities | 1 | 2003 | 451 | 0.040 |
Why?
| | Risk-Taking | 1 | 2003 | 323 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1028 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2023 | 502 | 0.040 |
Why?
| | Markov Chains | 1 | 2020 | 126 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 461 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1312 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 526 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2003 | 484 | 0.040 |
Why?
| | Students | 1 | 2003 | 661 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 169 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2007 | 1906 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 358 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2815 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 508 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 850 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 442 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 901 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 375 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2840 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1253 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 688 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1382 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1172 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1953 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1715 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2013 | 62 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 323 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1347 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2104 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2192 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 3166 | 0.020 |
Why?
| | Mesentery | 1 | 2007 | 45 | 0.020 |
Why?
| | Rupture, Spontaneous | 1 | 1986 | 15 | 0.020 |
Why?
| | Peritoneal Cavity | 1 | 1986 | 30 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2007 | 147 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 371 | 0.010 |
Why?
| | Actins | 1 | 2007 | 422 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2007 | 744 | 0.010 |
Why?
| | Midwestern United States | 1 | 2003 | 45 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2525 | 0.010 |
Why?
| | Sexually Transmitted Diseases | 1 | 2003 | 164 | 0.010 |
Why?
| | Contraception | 1 | 2003 | 169 | 0.010 |
Why?
| | Proteomics | 1 | 2007 | 1191 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 633 | 0.010 |
Why?
| | School Health Services | 1 | 2003 | 224 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5592 | 0.010 |
Why?
|
|
Roach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|